98 related articles for article (PubMed ID: 9439518)
1. Acetylator genotype and Parkinson's disease.
Paolini M
Lancet; 1998 Jan; 351(9096):141; author reply 142. PubMed ID: 9439518
[No Abstract] [Full Text] [Related]
2. Acetylator genotype and Parkinson's disease.
Nicholl DJ; Bennett P
Lancet; 1998 Jan; 351(9096):141-2. PubMed ID: 9439519
[No Abstract] [Full Text] [Related]
3. [The role of N-acetyltransferase polymorphism in the pathogenesis of Parkinson's disease].
Kłodowska-Duda GA; Opala GM; Ochudło SG
Neurol Neurochir Pol; 2003; 37(5):1095-101. PubMed ID: 15174255
[TBL] [Abstract][Full Text] [Related]
4. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.
Bialecka M; Gawronska-Szklarz B; Drozdzik M; Honczarenko K; Stankiewicz J
Eur J Clin Pharmacol; 2002 Feb; 57(12):857-62. PubMed ID: 11936704
[TBL] [Abstract][Full Text] [Related]
6. Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease.
Bandmann O; Vaughan JR; Holmans P; Marsden CD; Wood NW
Mov Disord; 2000 Jan; 15(1):30-5. PubMed ID: 10634239
[TBL] [Abstract][Full Text] [Related]
7. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
[No Abstract] [Full Text] [Related]
8. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
van der Walt JM; Martin ER; Scott WK; Zhang F; Nance MA; Watts RL; Hubble JP; Haines JL; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Mastaglia F; Roses AD; Stajich JM; Booze MW; Fujiwara K; Gibson RA; Middleton LT; Scott BL; Pericak-Vance MA; Vance JM
Neurology; 2003 Apr; 60(7):1189-91. PubMed ID: 12682333
[TBL] [Abstract][Full Text] [Related]
9. Acetylator genotype for N-acetyltransferase 2 and Parkinson's disease.
Dupret JM; Longuemaux S; Lucotte G
Ann Neurol; 1999 Sep; 46(3):433-4. PubMed ID: 10482279
[No Abstract] [Full Text] [Related]
10. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
11. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
Hein DW; Rustan TD; Bucher KD; Miller LS
J Pharmacol Exp Ther; 1991 Nov; 259(2):699-704. PubMed ID: 1941618
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study.
Harhangi BS; Oostra BA; Heutink P; van Duijn CM; Hofman A; Breteler MM
J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):518-20. PubMed ID: 10486401
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to bladder cancer.
Taioli E; Raimondi S
Lancet; 2005 Aug 20-26; 366(9486):610-2. PubMed ID: 16112283
[No Abstract] [Full Text] [Related]
15. Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians.
Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Singh S; Muthane UB; Juyal RC; B K T
Pharmacogenet Genomics; 2005 Oct; 15(10):731-5. PubMed ID: 16141799
[TBL] [Abstract][Full Text] [Related]
16. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk factors in Parkinson's disease: single gene effects and interactions of genotypes.
Göbel A; Macklin EA; Winkler S; Betensky RA; Klein C; Lohmann K; Simon DK
J Neurol; 2012 Nov; 259(11):2503-5. PubMed ID: 22878430
[No Abstract] [Full Text] [Related]
18. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
Hein DW; Kirlin WG; Ogolla F; Trinidad A
Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
[TBL] [Abstract][Full Text] [Related]
19. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
20. [Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease].
Białecka M; Droździk M; Podraza H
Neurol Neurochir Pol; 2002; 36(1):113-21. PubMed ID: 12053603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
